MiNK Therapeutics, Inc.
INKT
$11.90
$0.453.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -0.76% | -28.05% | -15.85% | 10.34% | 34.03% |
| Total Depreciation and Amortization | -28.51% | -21.28% | -15.55% | -8.32% | 4.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.51% | 297.07% | 459.13% | 296.81% | -43.29% |
| Change in Net Operating Assets | 46.75% | 607.21% | 615.25% | 60.01% | -2.68% |
| Cash from Operations | 10.51% | 24.39% | 37.99% | 48.64% | 36.80% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 245,612.66% | 210.40% | 155.93% | 132.76% | -99.86% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 176,940.51% | 117.08% | 36.06% | 25.20% | -99.93% |
| Foreign Exchange rate Adjustments | -340.58% | 69.47% | 75.64% | 45.52% | 70.76% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 193.36% | 343.63% | 625.95% | 11,380.85% | -483.28% |